NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Aktis Oncology, Inc. Common stock (AKTS)

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filters segment sells amplifier and filter products. It offers RF filters for the wireless industry, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company also sells complementary surface acoustic wave resonators, crystal (Xtal) resonators and oscillators, and ceramic products; and provides back-end semiconductor supply chain services. Akoustis Technologies, Inc. is headquartered in Huntersville, North Carolina.

Ticker
AKTS
Exchange
XNAS
Sector
Technology
Industry
Communication Equipment

Company profile updated October 14, 2026.

Stored market snapshot

As of October 12, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$17.34
Company market capitalization (USD)
$964,442,112.66
Price / book
1.99×

Research AKTS

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: